Skip to main content

Table 9 Clinical trials carried out with mesenchymal stem cells in feline asthma

From: Mesenchymal stem cells therapy in companion animals: useful for immune-mediated diseases?

Species (number)

Treatment

Results

Conclusion

Reference

Cat (6) Acute asthma

Five IV allogeneic ASCs (varied between 2 × 106 and 1 x 107per cat)

Decreased in: airway eosinophilia, hyper-responsiveness and airway remodeling

ASCs therapy had a positive effect on airway remodeling

[71]

Cat (9) Chronic asthma

Six IV allogeneic ASCs (with range amplitude of 0.36–2.5 × 107 MSCs/infusion)

Decreased in airway remodeling

[79]